Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature

The role and timing of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma receiving immunotherapy-based regimens is unclear. However, the ability to achieve a complete response for metastatic renal cell carcinoma likely requires a nephrectomy at some point during treatment. H...

Full description

Bibliographic Details
Main Authors:	Scott J. Dawsey, Steven C. Campbell, Moshe C. Ornstein
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Current Oncology
Subjects:	metastatic renal cell carcinoma immunotherapy cytoreductive nephrectomy case report
Online Access:	https://www.mdpi.com/1718-7729/28/3/178

Similar Items

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
by: Amanda Nizam, et al.
Published: (2020-01-01)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
by: Alex Renner, et al.
Published: (2019-03-01)

The impact of cytoreductive nephrectomy on survival outcomes in patients with metastatic renal cell carcinoma receiving immunotherapy: An evidence-based analysis of comparative outcomes
by: Kun-peng Li, et al.
Published: (2023-03-01)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
by: Hana Studentova, et al.
Published: (2023-07-01)

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

Cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Rajendra B Nerli
Published: (2013-01-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
by: Luigi Napolitano, et al.
Published: (2023-04-01)

Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?
by: Stamatios Katsimperis, et al.
Published: (2022-12-01)

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
by: Laura Iisager, et al.
Published: (2024-02-01)

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature
by: Hana Studentova, et al.
Published: (2022-08-01)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
by: Alexandr Poprach, et al.
Published: (2020-10-01)

Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
by: Benedikt Hoeh, et al.
Published: (2022-10-01)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
by: Yulin Zhou, et al.
Published: (2023-10-01)

The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis
by: Boda Guo, et al.
Published: (2021-04-01)

Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center
by: Kewei Chen, et al.
Published: (2023-06-01)

A rapid progression of new metastatic lesion after cytoreductive nephrectomy: A case report
by: Steven Steven, et al.
Published: (2021-11-01)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
by: Chen J, et al.
Published: (2020-03-01)

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis
by: Nessn Azawi, et al.
Published: (2024-03-01)

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
by: Yishan Zhang, et al.
Published: (2022-01-01)

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
by: Hiroaki Sato, et al.
Published: (2023-05-01)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
by: Ichiro Yonese, et al.
Published: (2020-07-01)

Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment
by: Sang Hun Song, et al.
Published: (2023-09-01)

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy
by: Zhao Zhang, et al.
Published: (2020-09-01)

Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
by: Amir F. Beirat, et al.
Published: (2023-02-01)

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
by: Wenjie Yang, et al.
Published: (2023-05-01)

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report
by: Takuya Nakagawa, et al.
Published: (2022-11-01)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01)

Severe Dyspnea due to Pulmonary Metastasis of Renal Cell Carcinoma: Is Cytoreductive Surgery of Value
by: Mohammad Kazem Moslemi, et al.
Published: (2010-09-01)

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals
by: Daniel D. Shapiro, et al.
Published: (2023-04-01)

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010
by: Lauri Laru, et al.
Published: (2021-06-01)

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?
by: Mohammed Shahait, et al.
Published: (2015-01-01)

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
by: Sara Elena Rebuzzi, et al.
Published: (2022-09-01)

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
by: Brian M. Shinder, et al.
Published: (2017-05-01)

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
by: Elisabeth E. Fransen van de Putte, et al.
Published: (2023-09-01)

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
by: Kan Wu, et al.
Published: (2020-12-01)

Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation
by: Takanari Kambe, et al.
Published: (2022-05-01)

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
by: Margaret F. Meagher, et al.
Published: (2024-05-01)

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
by: Scott J. Dawsey, et al.
Published: (2021-11-01)

Transdiaphragmatic nephrectomy with synchronous pulmonary and anterior thoracic wall mass metastasectomy in a young male with metastatic renal cell carcinoma; a single-incision approach
by: Lazaros Lazarou, et al.
Published: (2021-01-01)